2024 Angel Oregon Life + Bioscience
Angel Oregon Life & Bioscience (AOBIO) is designed to support early-stage life and bioscience startups based in Oregon and Southwest Washington by offering investment-readiness education, connectivity within the local bioscience community, and the opportunity to receive an equity investment from local angel investors.
The program is one in a series of Angel Oregon events facilitated by Oregon Entrepreneurs Network in collaboration with Oregon Bioscience Association, Oregon Bioscience Incubator/OTRADI, OHSU and Oregon Nanoscience and Microtechnologies Institute.
PRICING & REGISTRATION
OEN Member: $100
Non-Member: $150
INVESTMENT OPPORTUNITY
Early stage companies ready for dilutive capital investment may apply to this program.
What is an early stage company eligible to apply for investment through AOBIO?
Those with an established product/service, team, advisory board and roadmap may apply for consideration for the AOBIO equity investment.
The application will require a pitch deck and financials. Interested founders should be able to demonstrate traction for a proof of concept in the form of prior funding (via grants, loans, “friends & family”) and have a clear sense of the company’s valuation.
PROGRAM DETAILS
EDUCATION SESSIONS
- AOBIO will host TWO cohorts in 2024 featuring a three-week investment-readiness education series for life and bioscience startups at any stage of development.
- Cohort 1: Education Series
Thursdays, March 21st – April 11th – 8:30 – 10:00 am on Zoom - Cohort 2: Education Series
Thursdays, August 22nd – September 5th – 8:30 – 10:00 am on Zoom
- Cohort 1: Education Series
PITCH PRACTICE
- In-Person Practice Pitch session will be hosted by the Oregon Bioscience Incubator/OTRADI.
- Cohort 1: Pitch Practice
Thursday, April 18th – 11:00 am – 1:00 pm Oregon Bioscience Incubator/OTRADI
- Cohort 1: Pitch Practice
- Cohort 2: Pitch Practice
Thursday, September 19th – 11:00 am – 1:00 pm Oregon Bioscience Incubator/OTRADI
INVESTMENT MIXER
- AOBIO Investment Mixer will be held in-person on Thursday, November 21st from 5:00 – 7:00 pm.
EDUCATION SESSIONS
All education sessions will be conducted via Zoom. Content portions will be recorded and will be available to all registered participants following the session.
Investment Routes for Bio Startups
Thursday, March 21st
8:30 – 10:00 am
Featuring: Kabir Bhati, CEO – StoneStable, LLC, Anne Carlson, Associate Director, Technology Development and Licensing – OHSU and Charla Triplett, President – Catalyze LLC, and Tom Schnell, Team Lead / Finance Officer – Business Oregon
Getting money for life and bioscience startups can be a daunting task.
Life and bioscience companies are some of the most capital-intensive types of startups. Securing funding is required to make it through prolonged research and development timelines and navigate complex regulations. Research, clinical trials, regulatory approvals and intellectual property protection costs are enormous.
This AOBIO panel conversation will discuss the variety of opportunities available to life and bioscience companies, and the challenges of navigating the funding process.
Session Focus Points
- Government Grants
- Partnerships
- Angel Funding
Surviving Investor Due Diligence
Thursday, April 4th
8:30 – 10:00 am
Featuring: Nancy Lime, Entrepreneur In Residence – Oregon Nanoscience and Microtechnology Institute (ONAMI), Don Megrath, Co-Founder & Managing Director – VectorPoint Ventures, Travis Rush, Co-Founder & CEO – Reperio Health and Patti White, Co-Founder & CEO – Hemex Health
The goal of investor due diligence for a startup is to audit or review a company’s financial records, legal status, market positioning, and competitive landscape. This is done to catch anything that could hinder your company’s growth trajectory or compromise its ability to deliver on promises to investors, customers, and partners before it’s a problem
Successful due diligence requires careful planning and preparation. Understanding the process can help defuse many uncertainties and provide focus on the items that matter most.
This AOBIO conversation will teach participants what to expect during a due diligence audit and how to prepare — both logistically and mentally — for the entire process.
Session Focus Points
- Importance of Your Team
- Roadmap to Commercialization
- Legal, Regulatory, and Compliance Processes
- Financial Documentation (Data Room)
Demystifying the Term Sheet
Thursday, April 11th
8:30 – 10:00 am
Featuring: Liisa Bozinovic, Executive Director – Oregon Bioscience Association, Anne Bunnenberg, Founder and CEO – White Horse Consulting LLC, Meredith Fox – Partner, White Summers Caffee & James, LLP, and Ricardo López, Investment Strategist, Oregon Growth Board – Business Oregon
Raising capital for an emerging biotech company is rarely easy. For founders seeking funding, the term sheet is a critical document that can make or break a deal. It sets out the key terms that will form the building blocks of the relationship and alignment between the company and the investor.
More than just a financial contract, term sheets are about preserving your startup’s vision, protecting its interests, and ensuring a fair partnership with investors.
And this AOBIO panel conversation will help demystify term sheets, unraveling their significance, key components, and the critical art of negotiation.
Session Focus Points
- Cap Tables
- Valuation
- Protective Provisions
- Liquidations Preferences
- Anti-Dilution Protection
- Board Representation
- Registration Rights
- SAFE & Convertible Notes
ADDITIONAL INFORMATION
WHY IS AOBIO IMPORTANT FOR FOUNDERS AND ENTREPRENEURS?
- To build your business: learn how best to finance growth, meet investors, connect with mentors, and solve operational problems
- To build community: connect with fellow founders and investors in the bioscience sector, learn the stories behind home-grown successes, and grow your network
- To build the local economy: earn investment, find local suppliers, and meet local talent
WHO IS INVOLVED?
- FOUNDERS: Life & bioscience founders and founding teams of all kinds – therapeutics, diagnostics, medical device, health innovation – are welcome to register for the education sessions.
- ANGELS: accredited investors invest collectively in a life or bioscience company and help grow the regional bioscience sector are welcome. Details below.
- MENTORS: specialists of all kinds support founders with their time and talents in grant applications, business model development, regulatory compliance and testing, and so on.
THANK YOU SPONSORS
